Early Phase

The leading clinical trial supply conference in East Asia with a focus on providing delegates with practical take-aways and solutions to their most current operational and outsourcing challenges in clinical trials. This event focuses on the regional pharmaceutical business in Asia, highlighting the industry’s current difficulties as well as its exciting innovations and growth prospects.

This is the unmissable event that the pharmaceutical, biotechnology, and medical device communities need to come together and discuss strategies for operational success in clinical trials. Combining our OCT, CTS and Medical Devices events, this is the perfect platform for professionals from across a range of clinical trial functions to meet, network, and hear about latest developments.

The intersection of technology and best practice leads to breakthroughs within the clinical research enterprise. SCRS West: Clinical Tech & Innovation will focus on new thinking and collaborative problem solving to power the partnerships research needs.

New for 2022, take advantage of two tracks of content showcasing; Pre-IND & Early Clinical Development Exploring Assay Development for Best-in-Class Early-Stage Characterization; Establishing the Safety of Cell Therapy Products with Comprehensive Analytics Starting with the End-in-Mind: Considerations for Raw & Starting Material Analysis Optimizing Early-Stage Analytics to Bolster Speed to IND Submission & Phase 1 Launch Clinical Development & Commercialization; Improving Method Validation to Prepare for Successful Clinical Production; Approaching Later-Stage Analytical & Process Technology Transfers; Scaling Up from Clinical Development to Commercialization & Preparing for Release Optimizing Analytics During Manufacturing, Dealing with Process Changes

Over the past 10 years, CHI’s Immuno-Oncology Summit has become the leading annual meeting focusing on the latest applied research, providing comprehensive and in-depth coverage across all modalities and stages in the pipeline. Every year, we assemble an international mix of thought leaders and decision makers from industry and academia to bring you the latest developments in immuno-oncology, while providing access to a comprehensive 3-day program and extensive networking opportunities that CHI’s IO Summit provides.

DPHARM is designed for drug development innovative thinkers who are determined to re-invent clinical trials. Going into its fifteenth year, the conference explores how clinical trials can be reimagined to be more efficient, more patient-focused, more accurate, quicker and less costly.  The conference has become highly regarded among executives at Pharma companies, Biotechs and CROs.

DIA’s Digital Technology in Clinical Trials Conference will bring together thought leaders from regulatory agencies, biotech, pharma, patients, and academia to discuss the latest advances, challenges, and forwardthinking approaches for implementing digital technology to improve clinical trials.

Baird is delighted to host its annual Global Healthcare Conference. This conference brings institutional and private equity investors together with senior management from over 90 public and privately-held companies. The conference will feature companies across the following sectors: Biotechnology, Healthcare Supply Chain & Pharma Services, Healthcare Information Technology, Life Sciences & Diagnostics, Medical Technology and Facilities & Services. 

AusMedtech is Australia’s premier medical technology conference for medtech executives, providing business partnering opportunities for decision makers and investors.

Australia’s largest biotech event. Partnering opportunities for industry and investments. *** Early stage companies attendance component.